Multiple myeloma (MM) is a hematologic malignancy produced by a clonal expansion of plasma cells and characterized by abnormal production and secretion of monoclonal antibodies. This pathology exhibits an enormous heterogeneity resulting not only from genetic alterations but also from several epigenetic dysregulations. Here we provide evidence that Che-1/AATF (Che-1), an interactor of RNA polymerase II, promotes MM proliferation by affecting chromatin structure and sustaining global gene expression. We found that Che-1 depletion leads to a reduction of “active chromatin” by inducing a global decrease of histone acetylation. In this context, Che-1 directly interacts with histones and displaces histone deacetylase class I members from them. Strikingly, transgenic mice expressing human Che-1 in plasma cells develop MM with clinical features resembling those observed in the human disease. Finally, Che-1 downregulation decreases BRD4 chromatin accumulation to further sensitize MM cells to bromodomain and external domain inhibitors. These findings identify Che-1 as a promising target for MM therapy, alone or in combination with bromodomain and external domain inhibitors. Subjects:

Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma / T. Bruno, F. De Nicola, G. Corleone, V. Catena, F. Goeman, M. Pallocca, C. Sorino, G. Bossi, B. Amadio, G. Cigliana, M.R. Ricciardi, M.T. Petrucci, E.P. Spugnini, A. Baldi, M. Cioce, G. Cortese, E. Mattei, R. Merola, U. Gianelli, L. Baldini, F. Pisani, S. Gumenyuk, A. Mengarelli, K. Hopker, T. Benzing, B. Vincenzi, A. Floridi, C. Passananti, G. Blandino, S. Iezzi, M. Fanciulli. - In: BLOOD ADVANCES. - ISSN 2473-9537. - 4:22(2020 Nov 24), pp. 5616-5630. [10.1182/BLOODADVANCES.2020002566]

Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma

U. Gianelli;L. Baldini;
2020

Abstract

Multiple myeloma (MM) is a hematologic malignancy produced by a clonal expansion of plasma cells and characterized by abnormal production and secretion of monoclonal antibodies. This pathology exhibits an enormous heterogeneity resulting not only from genetic alterations but also from several epigenetic dysregulations. Here we provide evidence that Che-1/AATF (Che-1), an interactor of RNA polymerase II, promotes MM proliferation by affecting chromatin structure and sustaining global gene expression. We found that Che-1 depletion leads to a reduction of “active chromatin” by inducing a global decrease of histone acetylation. In this context, Che-1 directly interacts with histones and displaces histone deacetylase class I members from them. Strikingly, transgenic mice expressing human Che-1 in plasma cells develop MM with clinical features resembling those observed in the human disease. Finally, Che-1 downregulation decreases BRD4 chromatin accumulation to further sensitize MM cells to bromodomain and external domain inhibitors. These findings identify Che-1 as a promising target for MM therapy, alone or in combination with bromodomain and external domain inhibitors. Subjects:
Settore MED/15 - Malattie del Sangue
Settore MED/08 - Anatomia Patologica
13-nov-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
advancesADV2020002566.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.37 MB
Formato Adobe PDF
2.37 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/910901
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 7
social impact